Aetna Inc. (NYSE:AET) Stake Reduced by Independent Order of Foresters

Independent Order of Foresters decreased its stake in Aetna Inc. (NYSE:AET) by 5.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 915 shares of the company’s stock after selling 50 shares during the period. Independent Order of Foresters’ holdings in Aetna were worth $139,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. FTB Advisors Inc. boosted its stake in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new stake in Aetna during the first quarter valued at approximately $133,000. Liberty Capital Management Inc. boosted its stake in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares in the last quarter. Horan Capital Management acquired a new stake in Aetna during the first quarter valued at approximately $157,000. Finally, Guardian Life Insurance Co. of America boosted its stake in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. 91.73% of the stock is owned by institutional investors and hedge funds.

Shares of Aetna Inc. (NYSE:AET) opened at 152.42 on Friday. The company has a market capitalization of $50.62 billion, a price-to-earnings ratio of 33.83 and a beta of 0.54. The company’s 50-day moving average price is $154.28 and its 200-day moving average price is $138.79. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 EPS. On average, equities research analysts predict that Aetna Inc. will post $9.46 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.31%. Aetna’s payout ratio is currently 43.67%.

TRADEMARK VIOLATION WARNING: This story was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.com-unik.info/2017/08/11/aetna-inc-nyseaet-stake-reduced-by-independent-order-of-foresters.html.

Several equities research analysts recently commented on AET shares. Cowen and Company set a $170.00 target price on Aetna and gave the stock a “buy” rating in a research note on Saturday, May 27th. Credit Suisse Group reissued a “buy” rating and issued a $155.00 price objective on shares of Aetna in a research note on Wednesday, May 17th. UBS AG reissued a “buy” rating and issued a $160.00 price objective (up previously from $147.00) on shares of Aetna in a research note on Wednesday, May 17th. Bank of America Corporation reissued a “buy” rating and issued a $168.00 price objective (up previously from $160.00) on shares of Aetna in a research note on Wednesday, May 17th. Finally, Stifel Nicolaus raised their price objective on Aetna from $150.00 to $158.00 and gave the company a “buy” rating in a research note on Tuesday, May 16th. Eight equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Aetna presently has an average rating of “Buy” and a consensus target price of $157.09.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the sale, the executive vice president now directly owns 33,563 shares in the company, valued at approximately $5,008,606.49. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the sale, the chairman now owns 659,888 shares in the company, valued at $92,905,631.52. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit